time 3 (median = 9.00; p < 0.005). Conclusion: Knowledge increased following genetic counseling, but the highest total average score at any time was <70% out of 100%. Additional analyses revealed items with low rates of correct response at all three time points, raising several concerns and the consideration of alternative approaches to measuring knowledge.
Therefore, the American Society of Clinical Oncology recommends genetic counseling for BC survivors who may be at risk for hereditary breast and ovarian cancer (HBOC), as part of survivorship care guidelines [10] . Genetic counseling includes pretest genetic counseling, and for those who decide to proceed with testing, posttest genetic counseling.
Pretest genetic counseling involves evaluation of personal and family medical history, consideration of the benefits and limitations of genetic testing, a discussion of the potential results and the implications of those results on the individual and her family members [11] . According to professional organizations such as the National Society of Genetic Counselors, an essential part of pretest genetic counseling is improving knowledge and understanding to facilitate informed decision making about testing and risk-reducing procedures, as well as identify other family members who may be at risk for hereditary disease [12, 13] .
Increasing knowledge about hereditary cancer risk and medical management options for those who undergo testing is vital to ensuring informed decisions about testing, understanding of risk, and the measures to reduce their risk [14] [15] [16] . Previous studies found pretest genetic counseling increased patients' knowledge about HBOC [17] , and the knowledge increase was maintained over time [17] [18] [19] [20] . However, the majority of studies explored HBOC knowledge among unaffected individuals (i.e. who have not had cancer) [19, 21] , or a combination of those affected and unaffected [18, 22, 23] , and used a knowledge scale, National Center for Human Genome Research Knowledge Scale (NCH-GRKS) [24, 25] , that does not include items specifically relevant to BC survivors. Given their experience with cancer, BC survivors likely manage more health information than those who are unaffected, and may pay greater attention to information more relevant to their circumstance as a BC survivor. As part of a longitudinal study exploring the impact of genetic counseling and testing on cognitive and psychological outcomes, an earlier paper reported differences in outcomes before and after the pretest genetic counseling session related to knowledge, cancer-related distress, and decisional conflict between patients who attended pretest genetic counseling prior to, versus those who attended after definitive surgical treatment [26] . A second paper reported on communication of test results to family members and providers among a subset of BC survivors who pursued genetic testing [27] . This paper longitudinally explores changes in general HBOC knowledge among BC survivors using the NCHGRKS and 5 new items specific to BC survivors ( table 1 ), before and after pretest genetic counseling, and at a third time point, either 6 months after completion of their second assessment for those who did not pursue testing and 6 months after completion of their posttest counseling session for those who pursued testing. Specifically, we asked the following research questions: (1) How does BC survivors' overall knowledge about HBOC change over time? (2) How does BC survivor-specific knowledge about BC survivor-specific HBOC information change over time?
After the initial genetic counseling session, some BC survivors are likely to decide to undergo genetic testing, and as such will attend a second genetic counseling session where they will receive similar information to that which they learned at the first genetic counseling session. This re-exposure to HBOC information may increase their overall knowledge and recall at the third time point. Therefore, the second two research questions are: (3) Is there a difference in HBOC knowledge over time based on the decision to undergo genetic testing? (4) How does BC survivor-specific knowledge about BC survivor-specific HBOC information change over time based on the decision to undergo genetic testing?
Methodology
The methods used for the study are reported in greater detail in previous reports [26, 27] and are briefly summarized below.
Participants
Eligibility criteria included: (1) females with a genetic counseling appointment scheduled; (2) meeting National Comprehensive Cancer Network guidelines for referral to cancer genetic counseling; (3) ≥ 18 years of age; (4) a personal BC diagnosis, confirmed by medical record review; (5) no previous genetic counseling; (6) the ability to speak and write in English, and (7) having a mailing address and working telephone number. For the current study, analyses were limited to participants who completed the survey at all three study data collection time points described in the section below.
Procedure
Following Institutional Review Board approval, recruitment took place between April 2009 and July 2010 at a large cancer center in the South. Data were collected at three time points: time 1 (T1), after the pretest genetic counseling appointment was scheduled, but before the pretest genetic counseling session; time 2 (T2), 2-3 weeks after the pretest genetic counseling session, and time 3 (T3), 6 months after the T2 assessment for those who did not have genetic testing, and 6 months after the posttest genetic counseling session for those who had genetic testing.
Measures
Participants completed a self-administered survey at each data collection point. Demographic and clinical characteristics were collected at T1. The majority of items on the knowledge scale were from the NCHGRKS [24, 25] , originally consisting of 11 items, 1 of which was inadvertently excluded from the current survey ( table 1 ). The NCHGRKS includes questions about HBOC regarding the prevalence of BRCA1/2 , hereditary patterns, associated future cancer risks, and risk reduction options. Our team developed 5 additional BC-specific pilot items regarding: (1) residual cancer risk after mastectomy; (2) the importance for the affected woman to be the first in her family to be tested; (3) the possibility that genetic testing may not clarify personal BC etiology; (4) oophorectomy as a BC risk reduction option, and (5) the increased contralateral BC risk for BRCA mutation carriers ( table 1 ). These pilot items were reviewed by a multidisciplinary team for face and content validity.
The entire survey was pilot tested with a sample of 5 patients from the target audience. Response options to all scale items included 'true', 'false', and 'don't know'. The correct response to each question was either 'true' or 'false', where a correct answer received a score of 1; an incorrect or 'don't know' response received a score of 0. Total scores were calculated by summing the total number of correct responses for the NCHGRKS (possible range: 0-10), the total number of correct responses for the BC survivor-specific items (possible range: 0-5), and the total composite scale (possible range: 0-15). All items were equally weighted in calculating the total composite scale; therefore, the total composite scale score is more likely to reflect general knowledge from the NCHGRKS, rather than BC survivor-specific knowledge.
Data Analysis
Frequencies and percentages for participant demographic characteristics, practices, and confidence were obtained using SPSS 21. To assess and compare changes in knowledge over time using the original NCHGRKS [24, 25] , 5 items specific to BC survivors constructed for this study, and a total composite scale using 10 items from the NCHGRKS and the 5 items constructed for this study, Friedman's analyses of variance were conducted. To explore whether the second genetic counseling session impacted knowledge at T2 or T3, an independent-samples Mann-Whitney U test was conducted to assess differences between those who received a second counseling session and those who did not. Of the 114 participants who consented and participated at T1, 100 completed the assessments at T2 and 96 at T3. Analyses for this study were conducted using data from 96 participants who completed the knowledge scales at all three time points. There were no significant demographic or clinical differences between those who participated at all three time points and those who did not.
Participant demographic and clinical characteristics are presented in table 2 . On average, participants were 52 years old (SD = 10.48) at the time of study participation and were diagnosed with BC at age 49 (SD = 10.59). The majority was married or living with a partner (71.8%), white (84.4%), held at least an undergraduate degree (50.0%), had private insurance (52.1%), and an annual income of more than USD 50,000 per year (38.6%). Clinically, the majority was diagnosed in the 3 years prior to data collection (71.4%), reported diagnosis at stage 1 or 2 (45.9%), and received surgical treatment for their BC (94.8%). After the first genetic counseling session, most (77.1%) underwent genetic testing for a mutation in the BRCA genes. Of those who underwent genetic testing and chose to report their results to the study team, the majority (70.3%) received a negative result.
Knowledge
Results indicated a statistically significant difference over time using the NCHGRKS comprised of 10 items. Post hoc analysis revealed statistically significant differences in knowledge: an increase between T1 (median = 4.00) and T2 (median = 7.00; p < 0.005), a decrease between T2 and T3 (median = 6.00; p = 0.003), and an increase between T1 and T3 (p < 0.005; fig. 1 ).
Results indicated a statistically significant difference over time using the BC survivor-specific items constructed for this study comprised of 5 items. Post hoc analyses revealed a statistically significant difference in knowledge: an increase between T1 (median = 2.00) and T2 (median = 3.00; p < 0.005), and an increase between T1 and T3 (median = 3.00; p < 0.005), but no statistically significant change between T2 and T3 (p = 0.46; fig. 2 ).
Results indicated a statistically significant change over time using the total composite scale (i.e. 10 items from the NCHGRKS and 5 newly constructed items). Post hoc analyses revealed statistically significant changes in knowledge: an increase between T1 (median = 7.00) and T2 (median = 10.00; p < 0.005), a decrease between T2 and T3 (median = 9.00; p = 0.006), and an increase between T1 and T3 (p < 0.005; fig. 3 ). Data are presented as mean ± SD (range) or n (%). Some percentages do not sum to 100% due to missing data. Of the 96 participants included in this analysis, 74 (77.1%) underwent genetic testing, 20 (20.83%) did not, and 2 (2.08%) did not provide this information. Those who proceeded with testing attended a second genetic counseling session between T2 and T3. Results ( table 3 ) indicated no statistically significant difference in scores on the NCHGRKS at any of the three time points between those who underwent genetic testing and those who did not. There was no statistically significant difference in scores on the BC survivor-specific scores between those who underwent genetic testing and those who did not at T1. There was a statistically significant difference at T2 in BC survivor-specific knowledge, with those who underwent genetic testing scoring higher than those who did not (U = 477.5, z = -2.51; p = 0.012), and at T3 with those who underwent genetic testing scoring higher than those who did not (U = 365.5, z = -3.30; p = 0.001). There was no statistically significant difference in scores on the composite knowledge scale between those who underwent genetic testing and those who did not at T1 or T2.
However, there was a statistically significant difference at T3 in the composite knowledge scores with those who underwent genetic testing scoring higher on the composite knowledge scale (U = 410.5, z = -2.23; p = 0.026). To further examine participants' knowledge on BC-specific items, average scores for each knowledge question by time were calculated ( table 1 ).
Discussion
Historically, outcomes of genetic counseling emphasized the use of knowledge measures as education was determined to be an important aspect of genetic counseling [28] . Goals of genetic counseling were linked to those of other health education programs by promoting understanding of personal risk and the uptake of prevention behaviors [29] . Previous studies examined the impact of genetic counseling on knowledge among unaffected women [19] or a combination of unaffected and affected women [18, 22, 23] , and used a scale that does not include items more directly relevant to BC survivors. This study examined changes in knowledge of HBOC among BC survivors over time using the NCHGRKS and 5 additional items constructed by the study team to measure knowledge specific to BC survivors. Similar to findings from previous studies, participants' knowledge about HBOC increased following pretest genetic counseling T1, and although it decreased between T2 and T3, knowledge was still significantly higher at T3 than at T1 [17, 18, 20] .
BC survivors in our study who underwent testing had a second genetic test results-disclosure genetic counseling session; therefore, we explored whether there were differences in knowledge gains or maintenance resulting from re-exposure to the information. There was no difference between those who received the second genetic counseling session and those who did not on the NCHGRKS at any of the three time points; however, BC survivors who underwent genetic testing scored higher at T2 and T3 on the BC survivor-specific items.
There are several possible explanations for these findings. First, it may be that receiving information twice reinforced the information as predicted, but it is interesting that knowledge did not increase on the NCHGRKS as well. Perhaps the information most relevant to their situation (i.e. BC survivor-specific items) was most salient to women who believed they were at high risk for HBOC, and thus explains their decision to undergo testing. Specifically, women who believed genetic testing was a reasonable option following the pretest genetic counseling session may have given more attention to the issues particular to their situation as BC survivors, compared to those who opted not to pursue testing possibly due to a lower perceived risk for HBOC. It also is possible that the counselor placed less emphasis on information specific to BC survivors in the pretest genetic counseling session for those women who they believed were not appropriate genetic testing candidates, based on the genetic counselor's risk assessment. Second, it may be that the genetic counselor placed greater emphasis on survivor-specific information in the second genetic counseling session, thus increasing survivor-specific knowledge following the posttest genetic counseling session. Finally, it may be that women who underwent genetic testing may have perceived a greater risk for HBOC and therefore attended to issues particular to their situation as BC survivors more than those who opted not to pursue testing due to a lower perceived risk for HBOC. Future research is needed to validate these findings and explore other explanations if the findings hold. Although increases in knowledge were significant, on average, across all three time points participants in this study scored lower than 70% on the NCHGRKS, just above 50% on the 5 BC survivor-specific items, and just above 60% on the composite knowledge scale (NCHGRKS with the 5 additional BC-specific items). The low scores at T1 can be explained by the fact that participants had not undergone genetic counseling and thus had limited knowledge about HBOC. However, it is salient to note that total knowledge scores were barely above 60% at T2 and around 60% at T3. Similar to the results of this study, previous studies found statistically significant differences in knowledge from precounseling to postcounseling; however, an examination of the reported means revealed knowledge scores after genetic counseling in those studies remained at ≤ 70% following genetic counseling [30] , and just over 70% when interventions to improve outcomes were tested [23, 31] , confirming consistently low overall average scores.
At T2, most participants (90.7%) made the decision about whether or not to have genetic testing (data not shown). An informed decision in health care can be characterized as a decision made 'based on relevant, good quality information, and the resulting choice reflects the decision-maker's values' [32] . Results from this and previous studies raise questions about the quality of information that served as the basis for a patient's testing decision. If they do not have accurate knowledge about HBOC, is it still possible to make an informed decision regarding whether or not to undergo genetic testing? Although we did not examine decision making in this study, future research should consider how knowledge impacts decision making related to uptake of genetic testing.
At T3, it may seem a lower HBOC knowledge score is less concerning, especially since only 3 (3.1%) of the 74 (77%) who reported undergoing genetic testing received a positive test result (data not shown). However, regardless of the test result, women undergoing genetic testing are encouraged to share results with her family members [33] . Yet, studies identified communication with family members to be a complex process that often happens when the woman believes 'the time is right' which may be several months or years after genetic test results are known [34] . Therefore, ensuring accurate acquisition of, as well as recall and retrieval of HBOC knowledge over time is important for accurate and complete disclosure and dissemination of knowledge to other family members.
In addition to the overall low totals, scores on the 5 additional BC survivor-specific items remained particularly low at all three time points. Examining the items individually, none of the BC survivor-specific items scored above 65%, with the exception of the question about those with a BRCA mutation being more likely to develop a second BC (item 15), and scores on items 11, 12, and 14 were notably low at all three time points, failing to change significantly over time. Correct responses on item 6 significantly increased from T1 to T2, but <30% of participants answered correctly at any of the time points.
Although the NCHGRKS was developed in 1996, the core survey construct dimensions of HBOC (e.g. risks for cancer, patterns of inheritance, prevalence of BRCA mutations, and risk management options) remain important to understanding HBOC. However, the low average scores found in this study are consistent with findings in early applications of the scale [25] . In addition to considering whether certain items are not being covered in the genetic counseling session, and if the information is not being prioritized by the patients, it also may be valid to consider alternate methods of measuring knowledge.
It is unclear whether the educational-based or counseling-based (i.e. psychologically based) model is more effective [35] . The educational-based model emphasizes supporting the patient through education, facilitating informed decision making, providing impartial information, and correcting inaccurate information [36] . The counseling-based model emphasizes the provision of emotional support by facilitating the processing and integration of new information regarding their personal risk for cancer [36] . The current knowledge scale is based on information that providers and experts deemed important for patients to understand, but what is important to patients may differ. A great deal of complex information is provided during a genetic counseling session, and genetic counselors are trained to tailor the session to meet the patient's needs [28] . It is likely genetic counselors focus the content of the session on meeting the patients' needs in a manner that facilitates personal decision making, rather than ensuring 'standard' educational content is discussed. Indeed, the goal of genetic counseling as a psychoeducational process is to 'facilitate clients' ability to use genetic information in a personally meaningful way that minimizes psychological distress and increases personal control [37] . As such, a standard knowledge scale may not accurately capture unique knowledge or other outcomes gained from genetic counseling sessions and minimize other important outcomes that could influence patients' testing and treatment decisions.
For example, interviews with genetic counselors and their patients both identified the interpersonal interaction in the genetic counseling session as the most important determinate of a successful session [28] . However, results from a review of process studies examining the counselor-patient interaction found most genetic counseling sessions followed an educational approach, whereby the content was primarily biomedical information and the interaction was dominated by the genetic counselor [35] . Rather than exclusively using process studies or objective quantitative measures like those used in this study, it may be more prudent to combine these methods such that the process and the outcome can be implicitly examined.
Reviews of studies focused on other genetic counseling outcomes found subjective risk perception is more in-line with objective risk assessment following genetic counseling [38] , most individuals demonstrated positive psychosocial well-being following a genetic counseling session [39] , and genetic counseling did not cause negative affective outcomes [17] . Furthermore, results from this sample reported in an earlier paper found no changes in cancer distress or decisional conflict about genetic testing following the pretest genetic counseling session [26] . However, it is unclear what aspects of genetic counseling caused these positive changes. Rather than examine these outcomes as independent from knowledge, future studies should examine the effects of knowledge on the aforementioned outcomes as a means to identify how these outcomes may be interacting.
This study examined knowledge gains during genetic counseling for BRCA mutations. Although this study examined knowledge related to HBOC, findings from this study may have implications for exploring the impact of genetic counseling on knowledge for other hereditary cancers. Understanding knowledge gains during traditional and newer approaches to delivering genetic counseling will become increasingly important as testing for multiple cancer predisposition genes through panel testing or whole exome/whole genome sequencing is progressively implemented in practice. As more genes are tested, the amount of information provided to the patient will inherently increase. Finding novel methods to assess whether or not patients understand the information provided to them in a manner that facilitates meaningful decision making will become all the more important.
Limitations
Although the demographics of our participants match the demographics commonly seen at the institution, participants in this study were primarily white, highly educated, and with a high socioeconomic status, limiting the generalizability of the study results. The portion of the knowledge scale developed for our study had lower reliability at T2 and T3 which could not be improved through item reduction, but there are questions regarding the utility of conducting reliability analysis on knowledge scales, particularly diverse knowledge scales [40] . Scales developed to measure several different aspects of a particular illness or disease, for example: cause, risk, treatment, often tap into what has been called 'spotty knowledge' that is held by individuals as a result of receiving disjointed or sporadic information over time [40] . This may be particularly true when considering the variability that may occur in genetic counseling sessions to meet unique needs of patients. While the focus of this paper was on the examination of changes in knowledge related to BC survivors, it is important to keep in mind that the changes in the composite knowledge scale are more likely to reflect the changes in knowledge relevant for both affected and unaffected individuals as there were 10 items reflecting this more 'general' knowledge, and only 5 items were considered to be BC specific. Additional studies are needed to assess and confirm the validity of the knowledge items specific to BC survivors developed for this study. Data for this study were collected at a single institution, and genetic counseling was conducted by master's trained genetic counselors specializing in oncology, limiting the generalizability of this study to patients who may obtain genetic counseling in other contexts and/or from nongenetics providers.
Conclusion
BC survivors in this study increased their knowledge regarding HBOC following the receipt of cancer genetic counseling, and maintained that knowledge over time. However, on average, participants scored under 70% at all three time points. Additional analyses of the items on the scale identified specific areas in which knowledge does not seem to improve, raising questions about the educational content of the cancer genetic counseling session and/or the utility of the available measures used to assess HBOC knowledge.
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